Evidence map›Paper›PMID 26584255›Full record

ArticleMetabolic syndrome and related disorders2016

Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation.

Dennis Steverson, Ling Tian, Yuchang Fu, Wei Zhang, Elizabeth Ma, William Timothy Garvey

Open access · greenAbstract read
In one paragraph

Article in Metabolic syndrome and related disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TRIB3 Is a Hub Gene in Steatohepatitis and Aggravates Lipid Deposition and Inflammation in Hepatocytes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Dennis Steverson1 Department of Pathology, University of Alabama at Birmingham , Birmingham Alabama.
Ling Tian2 Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham Alabama.
Yuchang Fu2 Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham Alabama.
Wei Zhang2 Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham Alabama.
Elizabeth Ma2 Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham Alabama.
William Timothy Garvey2 Department of Nutrition Sciences, University of Alabama at Birmingham , Birmingham Alabama.
University of Alabama at Birmingham · USBirmingham VA Medical Center · US

Funding

Why is the prevalence of obesity so high in U.S. Southern States? Regional predictors of BMI and obesity treatment response.P30DK056336 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI James O Hill · 2000 to 2026
$31.9M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Kirk Michael Habegger · 2013 to 2026
$19.5M
UAB Pre-Doctoral Training Program in Obesity-Related ResearchT32HL105349 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2010 to 2026
$5.7M
MECHANISMS OF HUMAN INSULIN RESISTANCER01DK038765 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 1993 to 2010
$4.0M
NR4A Orphan Receptors And Insulin ResistanceR01DK083562 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GARVEY, W TIMOTHY · 2009 to 2012
$2.1M
ROLE OF GLUCOSE TRANSPORT PROTEINS IN DIABETES MELLITUSR29DK038765 · NIDDK · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI GARVEY, W TIMOTHY · 1988 to 1992
–
Pathogenesis of the Metabolic SyndromeI01CX000432 · VA · BIRMINGHAM VA MEDICAL CENTER · PI GARVEY, W TIMOTHY · 2011 to 2018
–
CSRD VA I01 CX000432NHLBI NIH HHS T32 HL105349NIDDK NIH HHS DK-038765NIDDK NIH HHS DK-083562NIDDK NIH HHS P30 DK056336NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

backgroundInsulin resistance is central in the pathophysiology of cardiometabolic disease; however, common mechanisms that explain the parallel development of both type 2 diabetes and atherosclerosis have not been elucidated. We have previously shown that tribbles homolog 3 (TRB3) can exert a chronic pathophysiological role in promoting insulin resistance and also has an acute physiological role to alternatively regulate glucose uptake in fat and muscle during short-term fasting and nutrient excess. Since TRB3 is expressed in human atherosclerotic plaques, we explored its role in foam cell formation to assess its potential contribution to atherogenesis.

methodsWe have used human THP-1 monocytes, which transition to lipid-laden macrophage foam cells when exposed to oxidized low-density lipoprotein (ox-LDL).

resultsWe first observed that TRB3 was upregulated by more than twofold (P < 0.01) within 24 hr of treatment with ox-LDL. To determine whether TRB3 actively participated in foam cell formation, we overexpressed TRB3 in THP-1 monocytes and found that this led to a 1.5-fold increase in cholesterol accumulation after 48 hr (P < 0.01), compared with controls. At the same time, TRB3 overexpression suppressed inflammation in macrophages as evidenced by reduced expression and secretion of tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) (both P < 0.01).

conclusions(1) TRB3 is upregulated in macrophages upon treatment with ox-LDL; (2) TRB3 promotes lipid accumulation and suppresses cytokine expression; and (3) inflammation and foam cell formation can be reciprocally regulated, and TRB3 orients the macrophage to assume a more primary role for lipid accumulation while maintaining a secondary role as an inflammatory immune cell.

Indexed as

AnimalsAtherosclerosisCell Cycle ProteinsCell Line, TumorCholesterolCytokinesDown-RegulationFatty Acid-Binding ProteinsFoam CellsHumansInflammationInflammation MediatorsInterleukin-1betaLipoproteins, LDLMiceProtein Serine-Threonine KinasesCell Cycle ProteinsCholesterolCytokinesFABP4 protein, humanFatty Acid-Binding ProteinsIL1B protein, humanInflammation MediatorsInterleukin-1betaLipoproteins, LDLoxidized low density lipoproteinProtein Serine-Threonine KinasesRepressor ProteinsTRIB3 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID26584255
PMCPMC4840829
OpenAlexW2177803101

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.